Last week, the Food and Drug Administration (FDA) released a “Drug Safety Communication,” warning that Veozah (fezolinetant), a new medicine to treat hot flashes due to menopause, can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback